Physician profile
Tracie Corn
NPI 1437625597
$765.79
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $342 · 2022: $285 · 2023: $109 · 2024: $30.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $139.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $202.36 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.98 | 2021-2022 | |
| Novo Nordisk INC | $84.55 | 2021-2023 | Wegovy |
| Lilly USA, LLC | $54.91 | 2021-2022 | |
| Glaxosmithkline, LLC. | $45.28 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $35.88 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $34.60 | 2021-2022 | |
| Dexcom, INC. | $24.46 | 2021 | |
| Philips North America LLC | $22.82 | 2022 | |
| Hologic Sales and Service, LLC | $22.65 | 2021 | |
| Novartis Pharmaceuticals Corporation | $22.36 | 2022 | |
| Genzyme Corporation | $18.01 | 2022 | |
| Amarin Pharma, INC. | $16.44 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.85 | 2021 | |
| Antares Pharma, INC. | $14.40 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $14.03 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $13.93 | 2021 | |
| Nestle Healthcare Nutrition INC. | $13.60 | 2021 | |
| Medtronic, INC. | $12.96 | 2023 | Intellis Adaptivestim |
| Kowa Pharmaceuticals America, INC. | $11.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracie Corn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.